Glenmark receives ANDA approval for Chlorpromazine Hydrochloride Tablets General Announcement Filing viewer · member access Original SGX announcement
Glenmark receives ANDA approval for Diltiazem Hydrochloride Capsules General Announcement Filing viewer · member access Original SGX announcement
Glenmark and Bausch Health join together to commercialize RYALTRIS nasal spray in Canada General Announcement Filing viewer · member access Original SGX announcement
Glenmark signs on Rohit Sharma as brand ambassador of Candid Powder General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Topiramate Extended Release Capsules General Announcement Filing viewer · member access Original SGX announcement
Mandatory Issuer's Early Redemption (Call Option) Filing viewer · member access Original SGX announcement
NOTICE TO HOLDERS OF THE REDEMPTION OF US$10,000,000 General Announcement Filing viewer · member access Original SGX announcement
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin fixed dose combination General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules General Announcement Filing viewer · member access Original SGX announcement
DISCLOSURE PURSUANT TO RULE 324(1) OF THE LISTING MANUAL General Announcement Filing viewer · member access Original SGX announcement
DISCLOSURE PURSUANT TO RULE 324(1) OF THE LISTING MANUAL General Announcement Filing viewer · member access Original SGX announcement
NOTICE TO HOLDERS OF THE REDEMPTION OF US$7,500,000 General Announcement Filing viewer · member access Original SGX announcement
GPL to divest select Anti-Allergy brands to Dr Reddys in Russia,Ukraine, Kazakhstana & Uzbekistan General Announcement Filing viewer · member access Original SGX announcement
NOTICE TO HOLDERS OF THE REDEMPTION OF US$182,500,000 General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Sirolimus Tablets General Announcement Filing viewer · member access Original SGX announcement
Glenmark introduces NINDANIB (Nintedanib) in India General Announcement Filing viewer · member access Original SGX announcement
No significant clinical benefit with Umifenovir addition in COVID-19 treatment General Announcement Filing viewer · member access Original SGX announcement
Submission of Annual Report General Announcement Filing viewer · member access Original SGX announcement
Outcome of the Board Meeting 14th August, 2020 General Announcement Filing viewer · member access Original SGX announcement
Board Meeting Intimation General Announcement Filing viewer · member access Original SGX announcement
Glenmark Announces Top-Line Results from Phase 3 Clinical Trial of Favipiravir General Announcement Filing viewer · member access Original SGX announcement
GPL commences 1000 patients Post Marketing Surveillance study with COVID-19 General Announcement Filing viewer · member access Original SGX announcement
Glenmark unlocks the treatment for Mild to Moderate Covid-19 in India General Announcement Filing viewer · member access Original SGX announcement
GPL to commence Phase 3 clinical trial on a combination of antiviral drugs Favipiravir & Umifenovir General Announcement Filing viewer · member access Original SGX announcement
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India General Announcement Filing viewer · member access Original SGX announcement